Researchers working on Covid vaccine that people can drink
Darpan News Desk IANS, 23 Jan, 2023 01:58 PM
San Francisco, Jan 23 (IANS) Researchers are working on a Covid-19 vaccine that people may drink instead of receiving with a needle, expanding their focus onto mucosal vaccines, which include nasal vaccines as well as "swish and swallow" oral vaccines.
The vaccine, called QYNDR, completed its phase 1 clinical trial and is currently waiting on more funding to conduct the more detailed, advanced trials that could actually bring the vaccine to market, reports CNET.
"The QYNDR vaccine is pronounced 'kinder', because it's a softer way to deliver a vaccine," Kyle Flanigan, founder of QYNDR's maker, US Specialty Formulations, was quoted as saying.
Moreover, the report said that promising clinical trial results from New Zealand offer hope that QYNDR will be a viable option for protection against the string of Covid-19 variants circulating now.
"It's really challenging to have a vaccine survive making it through your digestive system," Flanigan said.
"We were able to figure out how to get a vaccine past the stomach and into the gut and have it be effective and induce the appropriate response," she added.
Scientists are hopeful that mucosal vaccines will not only protect against severe diseases and death, as revolutionary mRNA vaccines and boosters have but also ward off infections, the report said.
Different from traditional vaccines, mucosal vaccines enter through our mucous membranes, either through our nose (as in the much-discussed nasal Covid-19 vaccine) or through our gut (as in the orally suspended QYNDRs).
Mucosal vaccines have been supported as viable, or even preferable, options for combating Covid-19 infections due to the different types of immunity they produce and the fact that it begins right where the virus enters our bodies, the report mentioned.
During this time of pandemic, ensuring the heath and safety of our residents, patrons and staff are the principles that determine the re-opening of City of Surrey recreational facilities.
A national clinical trial this summer will focus on protecting cancer patients against severe COVID-19 infection by attempting to boost their compromised immune system.
A safe haven in the U.S. where people can give themselves heroin and other drugs has observed more than 10,500 injections over five years and treated 33 overdoses with none proving fatal, researchers reported Wednesday.
The Centre of Excellence on Post-Traumatic Stress Disorder says health-care workers on the front lines of the COVID-19 pandemic are susceptible to severe stress that could cause long-term psychological damage.
